U.S. Markets open in 8 hrs 58 mins

Medical Cannabis Market will grow at CAGR of 29.3% to hit $56.70 Bn by 2026 - Global 2019 Analysis by Growth, Size, Share, Price, and Recent Initiatives: Adroit Market Research

Rising awareness regarding medical benefits of cannabis to fuel medical cannabis (medical marijuana) market by 2026. In 2018, North America dominates the global medical cannabis market by contributing over 90% of total revenue, of which majority comes from the U.S.

Dallas, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- The global medical cannabis market is expected to reach USD 56.70 billion by 2026. Increasing application of cannabis derived products to control symptoms of various diseases is expected to fuel the demand for medical cannabis in the coming years. Cannabis is effective in treatment of chronic pain, which is one of the leading medical conditions affecting a large portion of the American population. According to the National Health Interview Survey, more than 20 million people suffer from pain on daily basis within the U.S., with high economic burden of chronic pain. Medical cannabis is expected to show positive interventions in overcoming pain. Furthermore, increasing number of countries passing bills for legalization of medical marijuana is expected to spur the market growth in the years to come.

Request a PDF sample of the Global Medical Cannabis market research report @ https://www.adroitmarketresearch.com/contacts/request-sample/864

Continuous research on developing cannabis strains with highest medical value has been attracting large potential patient population. Additionally, various companies are concentrating on partnerships to expand their business and enter newer markets. For instance, in 2018, WeedMD partnered with Technion-Israel Institute of Technology for cannabis database project. The collaboration will research on cannabinoid & terpenoid profiles of WeedMD’s cannabis strains. Additionally, in 2017, the Oxford University declared its partnership with Kingsley Capital Partners, for developing marijuana based therapies for cancer, pain and many more disorders. These research initiatives are expected to change the perception of society towards cannabis and reduce social stigma.

The “Global Medical Cannabis Market Size by Indication (Pain Management, Neurological disorders, and others) by Region and Forecast 2016 to 2026” study provides an elaborative view of historic, present and forecasted market estimates. Access the full report@ https://www.adroitmarketresearch.com/industry-reports/medical-cannabis-market

In terms of indication, pain management dominated the global market by contributing over 60% of revenue and is expected to maintain its dominance by 2026. Large number of patients with chronic pain opting for medical cannabis is expected to drive the segment growth in the coming years. Furthermore, cannabis has been showing positive results in management of neurological diseases such as Epilepsy, Parkinson’s, and Alzheimer’s. CNS relaxant properties of chemical compounds present in marijuana are shown to reduce seizures in various patients. Similar research evidence are expected to bring new patient pool under cannabis consumption.

In terms of regional demarcation, North America dominated the global market and is expected to retain its command through the forecast period. U.S. and Canada both are the major countries with legalized medical cannabis and large number of users too. High level of awareness regarding medical benefits of cannabis in disease management is expected to drive the regional market. However, Europe and Asia Pacific are expected to grow at a faster pace compared to North America owing to recent legalization in some countries and growth phase of the market.

Buy the report@https://www.adroitmarketresearch.com/researchreport/purchase/864

Major points from Table of Contents:
Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4.  Medical cannabis Market Overview, By Indication
Chapter 5.  Key Country Market
Chapter 6.  Company Profiles


Grasp advance knowledge on Global Medical Cannabis Industry through in-depth Blogs, White Paper & Infographics:

Access the White Paper “All You Need To Know About Medical Cannabis” @ https://www.adroitmarketresearch.com/white-paper/all-you-need-to-know-about-medical-cannabis

Read the in depth blog titled “Medical Cannabis Helpful For Insomnia Patients” @ https://www.adroitmarketresearch.com/blogs/medical-cannabis-helpful-for-insomnia-patients

Access research repository of Upcoming Reports @ https://adroitmarketresearch.com/upcoming.html


About Us:
Adroit Market Research is a global business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.


Contact Us:
Ryan Johnson
Account Manager - Global
3131 McKinney Ave Ste 600
Dallas, TX 75204
Email ID: sales@adroitmarketresearch.com
Phone No.: +1 (214) 884-6068
Connect with us: Facebook | Twitter | LinkedIn